Clinical trials for patient with cancer of the brain and spinal cord
If you would like to be considered for a clinical trial you will require a referral from your current treating team. Visit the Joining a Clinical Trial page for referral information.
For more information on upper gastrointestinal cancer clinical trials, get in contact with our Monc A team
Trial ID Cancer type Glioblastoma Status Open and recruiting Phase Phase two / three: A phase two / three clinical trial follows a phase one / two, in a larger group of patients with specific cancer types. The aim of a phase two / three is to compare the new treatment to existing treatments available for that cancer type and closely monitor patients to make sure the treatment is safe and effective in that cancer type. Who can participate Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial. For full inclusion / exclusion criteria refer to ClinicalTrials.gov.
GBM AGILE
Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Trial ID Cancer type Glioma Status Open and recruiting Phase Phase Two: A phase two clinical trial follows a phase one, in a large group of patients with selected cancer types. The aim of a phase two is to find out if the new treatment is effective in these cancer types. Who can participate Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial. For full inclusion / exclusion criteria refer to the Australian New Zealand Clinical Trials Registry.
LUMOS2
Low and Anaplastic Grade Glioma Umbrella Study of Molecular Guided TherapieS
Trial ID Cancer type Medulloblastoma Status Recruitment on hold Phase Phase Two: A phase two clinical trial follows a phase one, in a large group of patients with selected cancer types. The aim of a phase two is to find out if the new treatment is effective in these cancer types. Who can participate Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial. For full inclusion / exclusion criteria refer to ClinicalTrials.gov.
PersoMed-I
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Trial ID Cancer type Low Grade Glioma with IDH1 Mutation Status Recruitment on hold Phase Phase one: A phase one clinical trial tests new treatments sometimes for the first time in humans, usually in a small group of patients. The aim of a phase one clinical trial is to test the safety of the new treatment and find the best dose to give patients. Who can participate Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial. For full inclusion / exclusion criteria refer to the Australian Cancer Clinical Trial Registry.
AnHeart
A Phase 0/2 Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma.